These findings suggested that once approved as a pharmaceutical agent, the Si-based agent could be highly expected to help alleviate the symptoms of UC because the range of efficacy of the Si-based agent was very wide
Response varies considerably between individuals
1 L-Carnitine has also been associated with a significant reduction in all-cause mortality, ventricular arrhythmias, and anginal symptoms in patients experiencing acute myocardial infarction
25 Wang K, Wang M, Liao X, Gao S, Hua J, Wu X, et al
The answer is bioavailability
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation